CYTOKINETICS Announces Q2 FY2023 Financial Results with 99.0% Year-Over-Year Revenue Decrease
🌥️Earnings Overview CYTOKINETICS ($NASDAQ:CYTK) reported their FY2023 Q2 earnings results on August 3 2023, with total revenue of USD 0.9 [...]
CYTOKINETICS Reports USD 0.9 Million Revenue and USD -128.6 Million Net Income in Q2 FY2023
🌥️Earnings Overview For the second quarter of its fiscal year ending June 30, 2023, CYTOKINETICS ($NASDAQ:CYTK) reported total revenue of [...]
Robert I Blum Sells 12500 Shares of Cytokinetics for $470875
☀️Trending News Cytokinetics ($NASDAQ:CYTK) is an American biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics to [...]
Cytokinetics Stock Intrinsic Value – Wall Street Analysts Predict 62.75% Rally for Cytokinetics Despite 0.2% Gain Last Week
Trending News 🌧️ Wall Street Analysts have predicted a 62.75% rally for Cytokinetics ($NASDAQ:CYTK) despite a 0.2% gain in the [...]
Cytokinetics Stock Fair Value – Cytokinetics Forced to Discontinue Phase 3 ALS Study After Failing to Demonstrate Clinical Benefit
Trending News 🌧️ Cytokinetics ($NASDAQ:CYTK), a biopharmaceutical company focused on developing novel therapies to treat serious diseases, has recently announced [...]
Cytokinetics Intrinsic Value Calculation – Analysts Upgrading Cytokinetics with “Overweight” Rating on 3/7/2023.
Trending News 🌧️ On 3/7/2023, analysts at Cantor Fitzgerald reaffirmed their "overweight" rating on Cytokinetics ($NASDAQ:CYTK), making them one of [...]
Cytokinetics Intrinsic Value Calculation – US FDA Issues Complete Response Letter to Cytokinetics, Shares Down 8% Post-Market Trading.
Trending News ☀️ Cytokinetics Intrinsic Value Calculation - The biopharmaceutical firm Cytokinetics ($NASDAQ:CYTK) recently received a major setback when the [...]
Glenmede Trust Co. NA Divests 5611 Shares of Cytokinetics, Incorporated.
Trending News ☀️ Cytokinetics ($NASDAQ:CYTK), Incorporated is a biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors [...]
Cytokinetics, Incorporated CEO Robert I. Blum Sells $424300.00 in Company Stock
Trending News 🌥️ Cytokinetics ($NASDAQ:CYTK), Incorporated, a biopharmaceutical company focused on developing treatments for neuromuscular and cardiovascular disorders, recently saw [...]
Cytokinetics Joins J.P. Morgan Healthcare Conference for 41st Year
Trending News 🌥️ Cytokinetics Stock Intrinsic Value – CYTOKINETICS ($NASDAQ:CYTK) (NASDAQ: CYTK) is a biopharmaceutical company focused on the discovery, [...]
